Stock 4555 SAWAI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Sawai Pharmaceutical Co., Ltd. Japan Exchange

Equities

4555

JP3323050009

Pharmaceuticals

Business Summary

Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.

Number of employees: 3,393

Sales per Business

JPY in Million2022Weight2023Weight Delta
Circulatory Organ Drug
24.5 %
51,415 26.5 % 49,135 24.5 % -4.43%
Central Nervous System Drug
21.0 %
35,357 18.2 % 42,147 21.0 % +19.20%
Others
9.7 %
18,525 9.6 % 19,520 9.7 % +5.37%
Digestive Medicine
9.2 %
19,004 9.8 % 18,357 9.2 % -3.40%
Blood - Fluid Drug
8.2 %
17,050 8.8 % 16,448 8.2 % -3.53%
Other Metabolic Drugs
7.9 %
13,622 7.0 % 15,827 7.9 % +16.19%
Antibiotic Preparation
4.0 %
7,329 3.8 % 8,033 4.0 % +9.61%
Vitamin Preparation
3.7 %
8,851 4.6 % 7,426 3.7 % -16.10%
Allergy Medication
3.3 %
6,884 3.6 % 6,522 3.3 % -5.26%
Urogenital Organ and Anus Medicine
3.0 %
5,670 2.9 % 6,033 3.0 % +6.40%
Drug for Tumor
2.8 %
5,033 2.6 % 5,662 2.8 % +12.50%
Respiratory Medicine
2.6 %
5,076 2.6 % 5,236 2.6 % +3.15%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
81.7 %
163,841 84.5 % 163,702 81.7 % -0.08%
United States
18.3 %
29,975 15.5 % 36,642 18.3 % +22.24%

Managers

Managers TitleAgeSince
Mitsuo Sawai CEO
 Chief Executive Officer 67 21-03-31
Kazuhiko Sueyoshi PSD
 President 66 21-03-31
Toru Terashima BRD
 Director/Board Member 64 21-03-31
Kenzo Sawai BRD
 Director/Board Member 55 21-03-31
Tadao Tsubokura AUD
 Comptroller/Controller/Auditor 63 21-03-31
Taku Nakaoka PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Mitsuo Sawai CEO
 Chief Executive Officer 67 21-03-31
Kenzo Sawai BRD
 Director/Board Member 55 21-03-31
Masatoshi Ohara BRD
 Director/Board Member 73 21-03-31
Kazuhiko Sueyoshi PSD
 President 66 21-03-31
Nawomi Todo BRD
 Director/Board Member 64 21-03-31
Toru Terashima BRD
 Director/Board Member 64 21-03-31

Shareholders

NameEquities%Valuation
Silchester International Investors LLP
8.839 %
3,871,600 8.839 % 154 M ¥
Nomura Asset Management Co., Ltd.
6.287 %
2,754,100 6.287 % 110 M ¥
JPMorgan Asset Management (Japan) Ltd.
3.893 %
1,705,100 3.893 % 68 M ¥
JPMorgan Asset Management (Asia Pacific) Ltd.
2.994 %
1,311,600 2.994 % 52 M ¥
Mitsuo Sawai
2.413 %
1,057,000 2.413 % 42 M ¥
Sawai Hiroyuki Family
2.269 %
994,000 2.269 % 40 M ¥
Kenzo Sawai
1.950 %
854,000 1.950 % 34 M ¥
Nikko Asset Management Co., Ltd.
1.655 %
725,000 1.655 % 29 M ¥
SUMITOMO MITSUI FINANCIAL GROUP, INC.
1.484 %
650,000 1.484 % 26 M ¥
Sawai Mitsuo KK
1.472 %
645,000 1.472 % 26 M ¥

Holdings

NameEquities%Valuation
SUMITOMO CORPORATION
0.07%
 858,000 0.07% 20,703,797 $
NIPPON KAYAKU CO., LTD.
0.51%
 875,000 0.51% 7,550,629 $
MEDIPAL HOLDINGS CORPORATION
0.10%
 218,100 0.10% 3,343,301 $
ALFRESA HOLDINGS CORPORATION
0.11%
 224,000 0.11% 3,289,438 $
YAKULT HONSHA CO.,LTD.
0.04%
 148,800 0.04% 3,066,551 $
MEDICAL IKKOU GROUP CO.,LTD.
3.44%
 140,000 3.44% 2,217,319 $
DAITO PHARMACEUTICAL CO.,LTD.
0.62%
 96,800 0.62% 1,499,218 $
ASAHI PRINTING CO.,LTD.
0.71%
 165,200 0.71% 985,666 $
SUSMED,INC.
1.46%
 245,000 1.46% 857,973 $
TECHNO RYOWA LTD.
0.14%
 31,460 0.14% 421,559 $

Company contact information

SAWAI GROUP HOLDINGS Co., Ltd.

5-2-30 Miyahara Yodogawa-Ku

532-0003, Osaka

+

http://www.sawaigroup.holdings
address Sawai Pharmaceutical Co., Ltd.(4555)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4887 Stock
  4. 4555 Stock
  5. Company Sawai Pharmaceutical Co., Ltd.